Anti-livin antibodies in Hashimoto thyroiditis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 11, 2012, Pages 527-530

  Baumann Antczak, Aleksandra ^a   Kosowicz, Jerzy ^a   Zamysołwska, Hanna ^a   Ruchaał, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti livin antibodies; Hashimoto thyroiditis

Indexed keywords

ANTIBODY; LIVIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; RADIOIMMUNOASSAY; THYROID CELL;

EID: 84872306923     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1454     Document Type: Article

References (21)

1. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis. 2007; 12: 1543-1568.
2. Schimmer AD, Daslili S. Targeting the IAP Family of caspase inhibitors as an emerging therapeutic strategy. Hematology Am Soc Hematol Educ Program. 2005; 215-219.
3. Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006; 13: 179-188.
4. Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 2000; 10: 1359-1366.
5. Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 2001; 276: 3238-3246.
6. Chang H, Schimmer AD. Livin/melanoma inhibitor of apoptosis protein is a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther. 2007; 6: 24-30.
7. Yagihashi A, Asanuma K, Tsuji N, et al. Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem. 2003; 49: 1206-1208.
8. Yagihashi A, Asanuma K, Kobayashi D, et al. Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung Cancer. 2005; 48: 217-221.
9. Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta. 2005; 362: 125-130.
10. Saif MW, Zalonis A, Syrigos K. The clinical significance of autoantibodies in gastrointestinal malignancies: an overview. Expert Opin Biol Ther. 2007; 7: 493-507.
11. El Ali Z, Grzymisławski M, Majewski P, et al. Anti-livin antibodies: novel markers of malignant gastrointestinal cancers. Pol Arch Med Wewn. 2010; 120: 26-30.
12. Salmaso C, Bagnasco M, Pesce G, et al. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann N Y Acad Sci. 2002; 966: 496-501.
13. Bossowski A, Czarnocka B, Stasiak-Barmuta A, et al. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases]. Endokrynol Pol. 2007; 58: 303-313. Polish.
14. Wang SH, Baker JR. The role of apoptosis in thyroid autoimmunity. Thyroid. 2007; 17: 975-979.
15. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002; 109: 97-107.
16. Kosowicz J, Furmaniak-Wehr J. [Determination of anti-thyroglobulin antibodies by solid phase radioimmunoassay]. Pol Arch Med Wewn. 1982; 67: 225-234. Polish.
17. Kosowicz J, Furmaniak-Wehr J, Ła̧cka K. [Radioimmunological method of determining antimicrosomal antibodies]. Endokrynol Pol. 1984; 35: 175-187. Polish.
18. Baumann-Antczak A, Kosowicz J. [Method for detection of antitubulin antibodies. Results of assays in autoimmune thyroid diseases]. Endokrynol Pol. 1992; 43: 451-460. Polish.
19. Baumann-Antczak A, Polańska A, Kosowicz J. [An association of autoantibodies to muscle proteins and autoimmune thyroid diseases]. Endokrynol Pol. 2001; 52: 35-47. Polish.
20. Ruchała M, Kosowicz J, Baumann-Antczak A, et al. The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA). Neuro Endocrinol Lett. 2007; 28: 259-266.
21. Abaci A, Bober E, Yesilkaya E, et al. Prevalence of anticardiolipin antibodies in type 1 diabetes and autoimmune thyroiditis. Pol Arch Med Wewn. 2010; 120: 71-75.